Volume 7 – Pediatric Lung Transplantation

SECTION 1: Referral Evaluation and Listing

CHAPTER 1: General Referral and Listing Criteria
CHAPTER 2: Disease Specific Issues Regarding Lung Transplantation

• Part A: Cystic Fibrosis
  Part B: Pulmonary Hypertension
• Part C: Sufactant Protein Abnormalities/chILD

CHAPTER 3: Timing of Listing and Patient Management on the Waiting List

SECTION II: Peri-transplant Management

CHAPTER 4: Pediatric Aspects of Lung Transplant Surgery - Including Historic Perspective
CHAPTER 5: Pediatric Issues of Donor Selection
CHAPTER 6: Early Post-operative Issues in the Intensive Care Unit

• Part A: Primary Graft Failure
• Part B: Pediatric ECMO Support

CHAPTER 7: Immunosuppression Induction & Maintenance Therapy

SECTION III: Post-transplant Complications and Co-morbidities

CHAPTER 8: Infectious Diseases Issues
CHAPTER 9: Monitoring for and Treatment of Acute Allograft Rejection
CHAPTER 10: Diagnosis and Management of Antibody-Mediated Rejection Following Pediatric Lung Transplantation
CHAPTER 11: Monitoring and Treatment of Bronchiolitis Obliterans Syndrome
CHAPTER 12: Gastroesophageal Reflux Disease
CHAPTER 13: Post-transplant Co-morbidities

• Part A: Chronic Kidney Disease
• Part B: Diabetes
• Part C: Bone Health

CHAPTER 14: PTLD and Cancer

SECTION IV: Outcomes

CHAPTER 15: Survival and Functional Status
CHAPTER 16: Special Populations

• Part A: Living Donor Lung Transplantation
• Part B: Infant Lung Transplantation
• Part C: Multi-organ Transplantation
• Part D: Re-transplantation

CHAPTER 17: Psychosocial Outcomes: Growth and Development
CHAPTER 18: Impact of Developmental Immunology on Outcomes

SECTION V: Psychosocial Aspects

CHAPTER 19: Care Transitions